2016-03-07 |
2016-03-03 |
A
Achat
|
Hagan Joseph P
Chief Operating Officer
Dirigeant
|
10 000
+inf%
7,19
71 900
USD
|
10 000
+inf%
|
7,19
|
71 900
USD
|
|
2016-02-24 |
2016-02-23 |
V
Vente
|
ALNYLAM PHARMACEUTICALS, INC.
Large shareholder
|
1 000 000
-17.0%
7,18
7 180 000
USD
|
1 000 000
-17.0%
|
7,18
|
7 180 000
USD
|
|
2015-08-13 |
2015-08-13 |
A
Achat
|
FOLETTA MARK G
Administrateur non-exécutif
|
10 000
+inf%
7,64
76 405
USD
|
10 000
+inf%
|
7,64
|
76 405
USD
|
|
2015-07-21 |
2015-07-21 |
A
Achat
|
RASTETTER WILLIAM H
Administrateur non-exécutif
|
61 235
+158.0%
10,19
624 199
USD
|
61 235
+158.0%
|
10,19
|
624 199
USD
|
|
2015-07-21 |
2015-07-20 |
A
Achat
|
RASTETTER WILLIAM H
Administrateur non-exécutif
|
38 765
+inf%
10,13
392 779
USD
|
38 765
+inf%
|
10,13
|
392 779
USD
|
|
2015-07-17 |
2015-07-17 |
V
Vente
|
ISIS PHARMACEUTICALS INC
Large shareholder
|
111 000
-2.1%
10,21
1 133 754
USD
|
111 000
-2.1%
|
10,21
|
1 133 754
USD
|
|
2015-07-17 |
2015-07-16 |
V
Vente
|
ISIS PHARMACEUTICALS INC
Large shareholder
|
167 000
-3.1%
10,79
1 801 362
USD
|
167 000
-3.1%
|
10,79
|
1 801 362
USD
|
|
2015-07-17 |
2015-07-15 |
V
Vente
|
ISIS PHARMACEUTICALS INC
Large shareholder
|
65 133
-1.2%
10,76
700 961
USD
|
65 133
-1.2%
|
10,76
|
700 961
USD
|
|
2015-07-02 |
2015-06-30 |
V
Vente
|
ISIS PHARMACEUTICALS INC
Large shareholder
|
13 248
-0.2%
10,79
143 010
USD
|
13 248
-0.2%
|
10,79
|
143 010
USD
|
|
2015-04-21 |
2015-04-21 |
VP
Vente planifiée
|
XANTHOPOULOS KLEANTHIS G
President and CEO
Administrateur exécutif
|
60 000
-94.2%
17,73
1 063 980
USD
|
60 000
-94.2%
|
17,73
|
1 063 980
USD
|
|
2015-04-21 |
2015-04-20 |
VP
Vente planifiée
|
XANTHOPOULOS KLEANTHIS G
President and CEO
Administrateur exécutif
|
66 071
-94.7%
16,85
1 113 514
USD
|
66 071
-94.7%
|
16,85
|
1 113 514
USD
|
|
2015-04-21 |
2015-04-17 |
VP
Vente planifiée
|
XANTHOPOULOS KLEANTHIS G
President and CEO
Administrateur exécutif
|
73 929
-95.2%
16,94
1 252 002
USD
|
73 929
-95.2%
|
16,94
|
1 252 002
USD
|
|
2015-04-14 |
2015-04-13 |
V
Vente
|
CARTER BRUCE L A
Administrateur non-exécutif
|
20 000
-100.0%
17,66
353 164
USD
|
20 000
-100.0%
|
17,66
|
353 164
USD
|
|
2015-03-05 |
2015-03-05 |
VP
Vente planifiée
|
XANTHOPOULOS KLEANTHIS G
President and CEO
Administrateur exécutif
|
23 616
-90.5%
20,81
491 551
USD
|
23 616
-90.5%
|
20,81
|
491 551
USD
|
|
2015-03-05 |
2015-03-05 |
VP
Vente planifiée
|
XANTHOPOULOS KLEANTHIS G
President and CEO
Administrateur exécutif
|
65 614
-71.6%
20,06
1 316 512
USD
|
65 614
-71.6%
|
20,06
|
1 316 512
USD
|
|
2015-03-03 |
2015-02-27 |
VP
Vente planifiée
|
XANTHOPOULOS KLEANTHIS G
President and CEO
Administrateur exécutif
|
70
-2.8%
19,50
1 365
USD
|
70
-2.8%
|
19,50
|
1 365
USD
|
|
2015-02-03 |
2015-02-02 |
VP
Vente planifiée
|
XANTHOPOULOS KLEANTHIS G
President and CEO
Administrateur exécutif
|
2 400
-49.3%
19,77
47 440
USD
|
2 400
-49.3%
|
19,77
|
47 440
USD
|
|
2015-02-03 |
2015-01-30 |
VP
Vente planifiée
|
XANTHOPOULOS KLEANTHIS G
President and CEO
Administrateur exécutif
|
3 300
-57.2%
19,50
64 351
USD
|
3 300
-57.2%
|
19,50
|
64 351
USD
|
|
2015-01-30 |
2015-01-29 |
VP
Vente planifiée
|
XANTHOPOULOS KLEANTHIS G
President and CEO
Administrateur exécutif
|
26 227
-91.4%
18,40
482 627
USD
|
26 227
-91.4%
|
18,40
|
482 627
USD
|
|
2015-01-30 |
2015-01-29 |
VP
Vente planifiée
|
XANTHOPOULOS KLEANTHIS G
President and CEO
Administrateur exécutif
|
33 773
-54.1%
17,77
600 008
USD
|
33 773
-54.1%
|
17,77
|
600 008
USD
|
|
2015-01-30 |
2015-01-28 |
VP
Vente planifiée
|
XANTHOPOULOS KLEANTHIS G
President and CEO
Administrateur exécutif
|
12 989
-84.0%
18,69
242 701
USD
|
12 989
-84.0%
|
18,69
|
242 701
USD
|
|
2015-01-30 |
2015-01-28 |
VP
Vente planifiée
|
XANTHOPOULOS KLEANTHIS G
President and CEO
Administrateur exécutif
|
72 011
-82.3%
17,97
1 293 814
USD
|
72 011
-82.3%
|
17,97
|
1 293 814
USD
|
|
2015-01-30 |
2015-01-28 |
VP
Vente planifiée
|
Gibson Neil W
Chief Scientific Officer
Dirigeant
|
8 655
-100.0%
18,66
161 493
USD
|
8 655
-100.0%
|
18,66
|
161 493
USD
|
|
2014-12-01 |
2014-11-28 |
VP
Vente planifiée
|
Gibson Neil W
Chief Scientific Officer
Dirigeant
|
1 500
-1.8%
19,63
29 445
USD
|
1 500
-1.8%
|
19,63
|
29 445
USD
|
|
2014-12-01 |
2014-11-28 |
VP
Vente planifiée
|
Gibson Neil W
Chief Scientific Officer
Dirigeant
|
1 000
-1.2%
18,80
18 800
USD
|
1 000
-1.2%
|
18,80
|
18 800
USD
|
|
2014-11-14 |
2014-11-12 |
V
Vente
|
ASTRAZENECA PLC
Large shareholder
|
2 000 000
-32.0%
17,00
34 000 000
USD
|
2 000 000
-32.0%
|
17,00
|
34 000 000
USD
|
|
2014-11-05 |
2014-11-03 |
V
Vente
|
ISIS PHARMACEUTICALS INC
Large shareholder
|
1 279 411
-18.8%
15,94
20 390 613
USD
|
1 279 411
-18.8%
|
15,94
|
20 390 613
USD
|
|
2014-10-31 |
2014-10-29 |
VP
Vente planifiée
|
Gibson Neil W
Chief Scientific Officer
Dirigeant
|
200
-0.2%
20,41
4 082
USD
|
200
-0.2%
|
20,41
|
4 082
USD
|
|
2014-10-31 |
2014-10-29 |
VP
Vente planifiée
|
Gibson Neil W
Chief Scientific Officer
Dirigeant
|
1 200
-1.5%
19,67
23 604
USD
|
1 200
-1.5%
|
19,67
|
23 604
USD
|
|
2014-10-31 |
2014-10-29 |
VP
Vente planifiée
|
Gibson Neil W
Chief Scientific Officer
Dirigeant
|
1 100
-1.3%
18,68
20 548
USD
|
1 100
-1.3%
|
18,68
|
20 548
USD
|
|
2014-10-31 |
2014-10-29 |
VP
Vente planifiée
|
XANTHOPOULOS KLEANTHIS G
President and CEO
Administrateur exécutif
|
100
-3.9%
20,41
2 041
USD
|
100
-3.9%
|
20,41
|
2 041
USD
|
|
2014-10-31 |
2014-10-29 |
VP
Vente planifiée
|
XANTHOPOULOS KLEANTHIS G
President and CEO
Administrateur exécutif
|
2 005
-43.9%
19,78
39 659
USD
|
2 005
-43.9%
|
19,78
|
39 659
USD
|
|
2014-10-31 |
2014-10-29 |
VP
Vente planifiée
|
XANTHOPOULOS KLEANTHIS G
President and CEO
Administrateur exécutif
|
1 400
-23.4%
18,66
26 124
USD
|
1 400
-23.4%
|
18,66
|
26 124
USD
|
|
2014-10-24 |
2014-10-24 |
VP
Vente planifiée
|
ALNYLAM PHARMACEUTICALS, INC.
Large shareholder
|
1 850
-0.0%
15,19
28 109
USD
|
1 850
-0.0%
|
15,19
|
28 109
USD
|
|
2014-10-24 |
2014-10-24 |
VP
Vente planifiée
|
ISIS PHARMACEUTICALS INC
Administrateur non-exécutif
Large shareholder
|
1 850
-0.0%
15,19
28 109
USD
|
1 850
-0.0%
|
15,19
|
28 109
USD
|
|
2014-10-24 |
2014-10-23 |
VP
Vente planifiée
|
ALNYLAM PHARMACEUTICALS, INC.
Large shareholder
|
1 700
-0.0%
14,24
24 202
USD
|
1 700
-0.0%
|
14,24
|
24 202
USD
|
|
2014-10-24 |
2014-10-23 |
VP
Vente planifiée
|
ISIS PHARMACEUTICALS INC
Administrateur non-exécutif
Large shareholder
|
1 700
-0.0%
14,24
24 202
USD
|
1 700
-0.0%
|
14,24
|
24 202
USD
|
|
2014-10-24 |
2014-10-22 |
VP
Vente planifiée
|
Gibson Neil W
Chief Scientific Officer
Dirigeant
|
3 300
-4.0%
14,44
47 644
USD
|
3 300
-4.0%
|
14,44
|
47 644
USD
|
|
2014-10-21 |
2014-10-20 |
VP
Vente planifiée
|
XANTHOPOULOS KLEANTHIS G
President and CEO
Administrateur exécutif
|
300
-10.8%
7,00
2 100
USD
|
300
-10.8%
|
7,00
|
2 100
USD
|
|
2014-10-21 |
2014-10-17 |
VP
Vente planifiée
|
XANTHOPOULOS KLEANTHIS G
President and CEO
Administrateur exécutif
|
400
-14.0%
7,04
2 816
USD
|
400
-14.0%
|
7,04
|
2 816
USD
|
|
2014-10-17 |
2014-10-17 |
VP
Vente planifiée
|
ISIS PHARMACEUTICALS INC
Administrateur non-exécutif
Large shareholder
|
3 000
-0.0%
6,79
20 371
USD
|
3 000
-0.0%
|
6,79
|
20 371
USD
|
|
2014-10-17 |
2014-10-17 |
VP
Vente planifiée
|
ALNYLAM PHARMACEUTICALS, INC.
Large shareholder
|
3 000
-0.0%
6,79
20 371
USD
|
3 000
-0.0%
|
6,79
|
20 371
USD
|
|
2014-10-17 |
2014-10-16 |
VP
Vente planifiée
|
ISIS PHARMACEUTICALS INC
Administrateur non-exécutif
Large shareholder
|
4 800
-0.1%
6,76
32 450
USD
|
4 800
-0.1%
|
6,76
|
32 450
USD
|
|
2014-10-17 |
2014-10-16 |
VP
Vente planifiée
|
ALNYLAM PHARMACEUTICALS, INC.
Large shareholder
|
4 800
-0.1%
6,76
32 450
USD
|
4 800
-0.1%
|
6,76
|
32 450
USD
|
|
2014-10-14 |
2014-10-14 |
V
Vente
|
XANTHOPOULOS KLEANTHIS G
President and CEO
Administrateur exécutif
|
400
-14.0%
7,00
2 800
USD
|
400
-14.0%
|
7,00
|
2 800
USD
|
|
2014-10-10 |
2014-10-10 |
VP
Vente planifiée
|
ISIS PHARMACEUTICALS INC
Administrateur non-exécutif
Large shareholder
|
2 000
-0.0%
6,41
12 813
USD
|
2 000
-0.0%
|
6,41
|
12 813
USD
|
|
2014-10-10 |
2014-10-10 |
VP
Vente planifiée
|
ALNYLAM PHARMACEUTICALS, INC.
Large shareholder
|
2 000
-0.0%
6,41
12 813
USD
|
2 000
-0.0%
|
6,41
|
12 813
USD
|
|
2014-10-14 |
2014-10-09 |
VP
Vente planifiée
|
XANTHOPOULOS KLEANTHIS G
President and CEO
Administrateur exécutif
|
105
-4.1%
7,00
735
USD
|
105
-4.1%
|
7,00
|
735
USD
|
|
2014-10-10 |
2014-10-09 |
VP
Vente planifiée
|
ISIS PHARMACEUTICALS INC
Administrateur non-exécutif
Large shareholder
|
4 750
-0.1%
6,58
31 238
USD
|
4 750
-0.1%
|
6,58
|
31 238
USD
|
|
2014-10-10 |
2014-10-09 |
VP
Vente planifiée
|
ALNYLAM PHARMACEUTICALS, INC.
Large shareholder
|
4 750
-0.1%
6,58
31 238
USD
|
4 750
-0.1%
|
6,58
|
31 238
USD
|
|
2014-10-03 |
2014-10-03 |
VP
Vente planifiée
|
ISIS PHARMACEUTICALS INC
Administrateur non-exécutif
Large shareholder
|
3 300
-0.0%
6,88
22 688
USD
|
3 300
-0.0%
|
6,88
|
22 688
USD
|
|
2014-10-03 |
2014-10-03 |
VP
Vente planifiée
|
ALNYLAM PHARMACEUTICALS, INC.
Large shareholder
|
3 300
-0.1%
6,88
22 688
USD
|
3 300
-0.1%
|
6,88
|
22 688
USD
|
|
2014-10-03 |
2014-10-02 |
VP
Vente planifiée
|
ISIS PHARMACEUTICALS INC
Administrateur non-exécutif
Large shareholder
|
3 750
-0.1%
6,64
24 903
USD
|
3 750
-0.1%
|
6,64
|
24 903
USD
|
|
2014-10-03 |
2014-10-02 |
VP
Vente planifiée
|
ALNYLAM PHARMACEUTICALS, INC.
Large shareholder
|
3 750
-0.1%
6,64
24 903
USD
|
3 750
-0.1%
|
6,64
|
24 903
USD
|
|
2014-10-02 |
2014-09-30 |
VP
Vente planifiée
|
XANTHOPOULOS KLEANTHIS G
President and CEO
Administrateur exécutif
|
2 300
-48.3%
7,02
16 137
USD
|
2 300
-48.3%
|
7,02
|
16 137
USD
|
|
2014-09-26 |
2014-09-26 |
VP
Vente planifiée
|
ISIS PHARMACEUTICALS INC
Administrateur non-exécutif
Large shareholder
|
2 500
-0.0%
7,04
17 598
USD
|
2 500
-0.0%
|
7,04
|
17 598
USD
|
|
2014-09-26 |
2014-09-26 |
VP
Vente planifiée
|
ALNYLAM PHARMACEUTICALS, INC.
Large shareholder
|
2 500
-0.0%
7,04
17 598
USD
|
2 500
-0.0%
|
7,04
|
17 598
USD
|
|
2014-09-26 |
2014-09-25 |
VP
Vente planifiée
|
ISIS PHARMACEUTICALS INC
Administrateur non-exécutif
Large shareholder
|
2 500
-0.0%
7,12
17 790
USD
|
2 500
-0.0%
|
7,12
|
17 790
USD
|
|
2014-09-26 |
2014-09-25 |
VP
Vente planifiée
|
ALNYLAM PHARMACEUTICALS, INC.
Large shareholder
|
2 500
-0.0%
7,12
17 790
USD
|
2 500
-0.0%
|
7,12
|
17 790
USD
|
|
2014-09-19 |
2014-09-19 |
VP
Vente planifiée
|
ISIS PHARMACEUTICALS INC
Administrateur non-exécutif
Large shareholder
|
4 100
-0.1%
7,22
29 587
USD
|
4 100
-0.1%
|
7,22
|
29 587
USD
|
|
2014-09-19 |
2014-09-19 |
VP
Vente planifiée
|
ALNYLAM PHARMACEUTICALS, INC.
Large shareholder
|
4 100
-0.1%
7,22
29 587
USD
|
4 100
-0.1%
|
7,22
|
29 587
USD
|
|
2014-09-19 |
2014-09-18 |
VP
Vente planifiée
|
ISIS PHARMACEUTICALS INC
Administrateur non-exécutif
Large shareholder
|
1 500
-0.0%
7,40
11 098
USD
|
1 500
-0.0%
|
7,40
|
11 098
USD
|
|
2014-09-19 |
2014-09-18 |
VP
Vente planifiée
|
ALNYLAM PHARMACEUTICALS, INC.
Large shareholder
|
1 500
-0.0%
7,40
11 098
USD
|
1 500
-0.0%
|
7,40
|
11 098
USD
|
|
2014-09-15 |
2014-09-12 |
VP
Vente planifiée
|
Gibson Neil W
Chief Scientific Officer
Dirigeant
|
2 200
-2.7%
8,01
17 617
USD
|
2 200
-2.7%
|
8,01
|
17 617
USD
|
|
2014-09-12 |
2014-09-12 |
VP
Vente planifiée
|
ALNYLAM PHARMACEUTICALS, INC.
Large shareholder
|
3 500
-0.1%
7,96
27 861
USD
|
3 500
-0.1%
|
7,96
|
27 861
USD
|
|
2014-09-12 |
2014-09-12 |
VP
Vente planifiée
|
ISIS PHARMACEUTICALS INC
Administrateur non-exécutif
Large shareholder
|
3 500
-0.1%
7,96
27 861
USD
|
3 500
-0.1%
|
7,96
|
27 861
USD
|
|
2014-09-15 |
2014-09-11 |
VP
Vente planifiée
|
Gibson Neil W
Chief Scientific Officer
Dirigeant
|
2 000
-2.4%
8,01
16 010
USD
|
2 000
-2.4%
|
8,01
|
16 010
USD
|
|
2014-09-12 |
2014-09-11 |
VP
Vente planifiée
|
ALNYLAM PHARMACEUTICALS, INC.
Large shareholder
|
3 400
-0.1%
7,83
26 636
USD
|
3 400
-0.1%
|
7,83
|
26 636
USD
|
|
2014-09-12 |
2014-09-11 |
VP
Vente planifiée
|
ISIS PHARMACEUTICALS INC
Administrateur non-exécutif
Large shareholder
|
3 400
-0.0%
7,83
26 636
USD
|
3 400
-0.0%
|
7,83
|
26 636
USD
|
|
2014-09-05 |
2014-09-05 |
VP
Vente planifiée
|
ISIS PHARMACEUTICALS INC
Administrateur non-exécutif
Large shareholder
|
2 400
-0.0%
7,07
16 974
USD
|
2 400
-0.0%
|
7,07
|
16 974
USD
|
|
2014-09-05 |
2014-09-05 |
VP
Vente planifiée
|
ALNYLAM PHARMACEUTICALS, INC.
Large shareholder
|
2 400
-0.0%
7,07
16 974
USD
|
2 400
-0.0%
|
7,07
|
16 974
USD
|
|
2014-09-05 |
2014-09-04 |
VP
Vente planifiée
|
ISIS PHARMACEUTICALS INC
Administrateur non-exécutif
Large shareholder
|
6 000
-0.1%
7,11
42 656
USD
|
6 000
-0.1%
|
7,11
|
42 656
USD
|
|
2014-09-05 |
2014-09-04 |
VP
Vente planifiée
|
ALNYLAM PHARMACEUTICALS, INC.
Large shareholder
|
6 000
-0.1%
7,11
42 656
USD
|
6 000
-0.1%
|
7,11
|
42 656
USD
|
|
2014-08-29 |
2014-08-29 |
VP
Vente planifiée
|
ISIS PHARMACEUTICALS INC
Administrateur non-exécutif
Large shareholder
|
1 500
-0.0%
6,84
10 254
USD
|
1 500
-0.0%
|
6,84
|
10 254
USD
|
|
2014-08-29 |
2014-08-29 |
VP
Vente planifiée
|
ALNYLAM PHARMACEUTICALS, INC.
Large shareholder
|
1 500
-0.0%
6,84
10 254
USD
|
1 500
-0.0%
|
6,84
|
10 254
USD
|
|